StockData
Citius Oncology, Inc. logo

Citius Oncology, Inc. (CTOR) stock

CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.56+0.01 (+1.79%)

Close on Nov 18, 2026Market cap $51.83MP/E –Yield –

Citius Oncology gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$1.00M–
Q2 FY2026CQ1 2026Mar 31, 2026$1.34M–
Q1 FY2026CQ4 2025Dec 31, 2025$3.15M–

More Citius Oncology figures

See a number that looks wrong?